Perforin inhibition protects from lethal endothelial damage during fulminant viral hepatitis
M Welz, S Eickhoff, Z Abdullah, J Trebicka, KH Gartlan, JA Spicer, AJ Demetris, H Akhlaghi, M Anton, K Manske, D Zehn, B Nieswandt, C Kurts, JA Trapani, P Knolle, D Wohlleber, W Kastenmueller
Nature Communications | NATURE PUBLISHING GROUP | Published : 2018
Awarded by german research foundation DFG
Awarded by DFG
Awarded by European Union
We would like to thank C. Boerner, S. Ebbinghaus, S. Rathmann, and K. Dumler for technical assistance. This research was supported by the german research foundation DFG (SFB 704, SFB 670, and TRR 179). W.K., Z.A., and C. K. are members of the DFG Excellence Cluster ImmunoSensation in Bonn, Germany. W.K. is supported by NRW-Ruckkehrerprogramm of the German state of Northrhine-Westfalia. D.W. was supported from BONFOR. J.T. was supported by DFG (SFB TRR57 P18), European Union's Horizon 2020 research, the innovation programme (No. 668031), and the Cellex Foundation. P.K. was supported by the German Center for Infection Research, Munich Site.